Skip to main content
SpringerLink
Log in

A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to develop a Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and assess its reliability, validity, and sensitivity to change. The Turkish version was obtained after a translation and back-translation process. Seventy-one patients with ankylosing spondylitis were assessed with it. To assess its validity, patients were also evaluated with the Turkish version of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Metrology Index (BASMI), the Bath Ankylosing Spondylitis Patient Global Score (BAS-G), and physicians’ assessments of disease activity. Over 24 h, the Turkish BASDAI did not show significant differences between the two assessments (P>0.05). Correlations were found between BASDAI and all of the evaluation parameters except BASMI (P<0.01). Both BASDAI and BASMI showed significant improvements after 8-week home exercise programmes. The results of this study show that the Turkish version of the BASDAI is reliable, valid, and sensitive to change.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Russell AS (1998) Ankylosing spondylitis: history. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp 1–2

  2. Calin A (1987) Editorial. Assessing disease activity in AS. Lancet 1:1072

    PubMed  Google Scholar 

  3. Taylor HG, Wardle T, Beswick EJ et al (1991) The relationship of clinical and laboratory measurements to radiological change in AS. Br J Rheumatol 30:330–335

    CAS  PubMed  Google Scholar 

  4. Calin A (1995) The individual with ankylosing spondylitis: defining disease status and impact of illness. Br J Rheumatol 34:663–672

    CAS  PubMed  Google Scholar 

  5. Pyle KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO (1991) Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 30:29–34

    PubMed  Google Scholar 

  6. Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970

    CAS  PubMed  Google Scholar 

  7. Kennedy L, Jenkinson T, Mallorie T, Whitelock H, Garrett S (1995) Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 34:767–770

    CAS  PubMed  Google Scholar 

  8. Mander M, Simpson JM, McLennan A, Walker D, Goodacre JA, Carson Dick W (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197–202

    CAS  PubMed  Google Scholar 

  9. Kennedy LG, Edmuns L, Calin A (1993) The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol 20:688–692

    CAS  PubMed  Google Scholar 

  10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    CAS  PubMed  Google Scholar 

  11. Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F, Clerc D, Berthelot JM, Vergne P, Roudot-Thoraval F, Larget-Piet B, Chevalier X (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 24:1954–1958

    CAS  PubMed  Google Scholar 

  12. Waldner A, Cronstedt H, Stenström CH (1999) The Swedish version of Bath ankylosing spondylitis disease activity index. Reliability and validity. Scand J Rheumatol 28 [Suppl 111]:10–16

    Google Scholar 

  13. Brandt J, Westhoff G, Rudwaleit M, Listing J, Zink A, Braun J, Sieper J (2003) Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumatol 62:264–273

    CAS  PubMed  Google Scholar 

  14. Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R (2003) Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451–458

    CAS  PubMed  Google Scholar 

  15. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    PubMed  Google Scholar 

  16. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  17. Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71

    Google Scholar 

  18. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698

    CAS  PubMed  Google Scholar 

  19. Scalapino KL, Davis JC Jr (2003) The treatment of ankylosing spondylitis. Clin Exp Med 2:159–165

    Article  CAS  PubMed  Google Scholar 

  20. Haywood KL, Garratt AM, Dziedzic K, Dawes PT (2002) Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 41:1380–1387

    Google Scholar 

  21. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS (2002) A six-month randomised, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766–773

    Article  CAS  PubMed  Google Scholar 

  22. Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43:1346–1352

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Ege University Medical Faculty, Izmir, Turkey

    Yesim Akkoc, Altinay Goksel Karatepe & Yesim Kirazli

  2. Department of Rheumatology, Division of Internal Medicine, 9 Eylul University Medical Faculty, Izmir, Turkey

    Servet Akar & Nurullah Akkoc

  3. Ege Universitesi Tıp Fakultesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, 35100, Bornova-Izmir, Turkey

    Yesim Akkoc

Authors
  1. Yesim Akkoc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Altinay Goksel Karatepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Servet Akar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yesim Kirazli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nurullah Akkoc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yesim Akkoc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akkoc, Y., Karatepe, A.G., Akar, S. et al. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25, 280–284 (2005). https://doi.org/10.1007/s00296-003-0432-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-003-0432-y

Keywords

Search

Navigation